Global Molecular Diagnostics Market Analysis–Trends, Insights and Forecasts (2021-2027)

  • Publish Date
    March 14, 2022
  • No of Pages
    380
  • SKU Code
    GIR 8049
  • Format

Global Molecular Diagnostics market – Overview

  • The report will cover the overall analysis and insights in relation to the size and growth rate of the “Global Molecular Diagnostics market ” by various segments at a global and regional level for the 2014-2027 period, with 2014-2019 as historical data, 2020 as a base year, 2021 as an estimated year and 2021-2027 as forecast period.

Global Molecular Diagnostics market – Introduction

  • Molecular diagnostics is the most effective method for identifying and characterizing This test must be precise, quick, and capable of identifying the organism’s strain and drug susceptibility more quickly. Molecular diagnostic tests are used to detect specific sequences in DNA or RNA, including single nucleotide polymorphism (SNP), deletions, rearrangements, insertions, and others to further diagnose the disease. These are cumulative techniques for analyzing biological markers at the molecular level, such as genome and proteome. These techniques are used for diagnosis of the various infectious diseases, cancer, and others and is also used to check the genetic predisposition to a disease.
  • The popularity of molecular diagnostics is increasing continuously in life sciences industry due to its wide application for disease diagnosis on molecular level. However, high cost of instruments and molecular diagnostics test will hamper the overall molecular diagnostics market growth.
  • Rising incidence of cancer worldwide and growing demand for point-of-care (POC) diagnostics in developing countries is anticipated to drive the molecular diagnostics market progression over the forecast period.

 

Report Includes

  • A brief overview of the commercial potential of products, technologies and applications.
  • Description of properties and manufacturing processes.
  • Discussion of the current state, setbacks, innovations, and the future needs of the market.
  • Detailed discussion regarding impact of product on demand
  • Up-to-date analyses of market trends and technological improvements in the market
  • Examination of the market by application and by product sizes; utility scale, medium scale and small scale.
  • To strategically profile key players and comprehensively analyze their market rankings and core competencies
  • The report focuses on detailed profile of major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information.
  • Coverage of historical overview, key industrial development and regulatory framework.

Global Molecular Diagnostics market Report Scope

  • The scope of the report covers the clear understanding and overview of the product.
  • Analysis of market trends in the region, with market data considering 2020 as the base year, 2021 as the estimate year and forecast for 2027 with projection of CAGR from 2021 to 2027.
  • The report covers discussion of economic trends and technology.
  • Market estimates represent revenue.
  • In-depth analysis of the market segmentation assists in determining the prevailing market scope.
Attribute Details
Market size available for years 2014–2027
Base year considered 2020
Forecast period 2021–2027
Historical period 2014-2019
Forecast units Value (USD) & Volume (Million Units)
Segmentation By Regions
North America, Europe, Asia Pacific, Latin America and Middle East & Africa
By Countries
United States, Russia, China, Germany, United Kingdom, France, Japan, Israel, Saudi Arabia, South Korea, United Arab Emirates, Canada, Indonesia, Malaysia, Switzerland, Australia, India, Italy, Sweden, Spain, Belgium, Netherlands, Norway, Brazil, Argentina, Mexico, South Africa and 54 Others.
By Product
Reagents & Kits, Instruments, Software & Service.
By Technology
Polymerase Chain Reaction (PCR), In-Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Sequencing, Chips & Microarrays, In Situ Hybridization (ISH) and Others.
By Application
Infectious Disease, Blood Screening, Histology & Oncology, Genetic Testing and Other.
Companies covered Abbott Laboratories; ABACUS Diagnostica Oy; Agilent Technologies, Inc.; Amoy Diagnostics Co., Ltd.; Becton; BD; bioMerieux SA; Bio-Rad Laboratories, Inc.; Biocartis NV; Cepheid; Dickinson and Company; DiaSorin S.p.A; Danaher Corporation; Exact Sciences Corporation; ELITechGroup; F. Hoffmann-La Roche Ltd.; Grifols International, S.A.; Genetic Signatures; GenMark Diagnostics Inc.; Hologic, Inc.; HTG Molecular Diagnostics; Illumina, Inc.; Luminex Corporation; Myriad Genetics Inc.; MDxHealth; Molbio Diagnostics Pvt. Ltd.; QIAGEN N.V.; QuestDiagnostics, Inc.; Quidel Corporation; Siemens Healthcare GmbH; Sysmex Corporation; Savyon Diagnostics Ltd.;  Tecan Group Ltd.; TBG Diagnostics Ltd.  The ELITechGroup; Thermo Fisher Scientific; Vela Diagnostics and Others.

Segments Covered in Global Molecular Diagnostics market

  • The global Molecular Diagnostics market is divided into different segments on the basis of Product, types, Technology, Application, and region. The Molecular Diagnostics market segment on the basis of Product includes Reagents & Kits, Instruments, Software & Service. On the basis of Technology, the Molecular Diagnostics market segment comprises a Polymerase Chain Reaction (PCR), In-Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Sequencing, Chips & Microarrays, In Situ Hybridization (ISH) and many more. The global Molecular Diagnostics market segment by the Application involves Infectious Disease, Blood Screening, Histology & Oncology, Genetic Testing and many other sectors. Infectious diseases held an estimated 60.0% of the market share in 2017.
  • The global Molecular Diagnostics market segment on the basis of region includes Europe, Asia-Pacific, North America, and other parts of the world. Moreover, higher potential for intense penetration of advanced diagnostics in the Asia Pacific market may offer significant share for the companies in terms of revenue in the global molecular diagnostics market.

Covid-19 Impact on the Global Molecular Diagnostics market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. With the COVID-19 pandemic, responding to infectious disease has become a pressing medical issue worldwide. In addition to the development of vaccines and drugs, there is a growing call for the development of more precise and simple testing technologies and the expansion of testing structures. COVID-19 has also impacted the regulatory environment and practices, as governments and healthcare providers face unprecedented challenges. Regulatory authorities utilized methods to speed approval of diagnostic products. Companies have taken strategic developments to introduce COVID-19 rapid tests, sustain their revenues, and nullify the impact of COVID-19 on their operational capabilities

Recent Developments in Global Molecular Diagnostics market

  • March 2021 -QIAGEN N.V. made an announcement of the launch of the QIAcube Connect MDx, an adaptable platform for automated sample processing to be available to molecular diagnostic laboratories in the U.S. and Canada and other markets globally.
  • April 2020 – BD, a medical technology company, and BioGX Inc., a molecular diagnostics company, made an announcement of submitting the Emergency Use Authorization requests for the approval of new diagnostic test to U.S. Food and Drug Administration (FDA) which when approved will allow hospitals to screen for COVID-19 and get the results in three hours.

Key Market Players in Global Molecular Diagnostics market

  • The major players in the Global Molecular Diagnostics market are Abbott Laboratories; ABACUS Diagnostica Oy; Agilent Technologies, Inc.; Amoy Diagnostics Co., Ltd.; Becton; BD; bioMerieux SA; Bio-Rad Laboratories, Inc.; Biocartis NV; Cepheid; Dickinson and Company; DiaSorin S.p.A; Danaher Corporation; Exact Sciences Corporation; ELITechGroup; F. Hoffmann-La Roche Ltd.; Grifols International, S.A.; Genetic Signatures; GenMark Diagnostics Inc.; Hologic, Inc.; HTG Molecular Diagnostics; Illumina, Inc.; Luminex Corporation; Myriad Genetics Inc.; MDxHealth; Molbio Diagnostics Pvt. Ltd.; QIAGEN N.V.; QuestDiagnostics, Inc.; Quidel Corporation; Siemens Healthcare GmbH; Sysmex Corporation; Savyon Diagnostics Ltd.; Tecan Group Ltd.; TBG Diagnostics Ltd.  The ELITechGroup; Thermo Fisher Scientific; Vela Diagnostics and Others.
  • Also, the Molecular Diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
  • Abbott Laboratories are expected to lead the global market during the forecast period. Optimal research & development strategies, robust supply chain network, increasing investments in research & development and cost management are projected to serve huge opportunity for the aforementioned market players to lead this market during the forecast period.

Objectives of the study

To provide detailed information regarding drivers, restraints, opportunities and challenges are influencing the growth in the respective market. To analyze the competitive intelligence of players based on company profiles and their key growth strategies. To strategically analyze micro markets with respect to the individual growth trends, their prospects, and their contribution to the total respective market. To analyze competitive developments such as expansions, and product launches, along with research & development (R&D) activities undertaken in the respective market. A unique model is created customized for each study also offers suggestions that help enterprises to identify and mitigate risks.

Note –

  • Global Industry Reports will also support you post-purchase for a period of 6 months to answer any of your queries related to the following market and to provide you any more data if you need, for your analysis.
  • Also, you can buy some selected Chapters from the report.

INTRODUCTION

Objectives of the study

Global Molecular Diagnostics market definition

Global Molecular Diagnostics market scope

Global Molecular Diagnostics market Stakeholders

Global Molecular Diagnostics market Limitations

Summary of changes

RESEARCH METHODOLOGY

Research data

Secondary data

Primary data

Global Molecular Diagnostics market size estimation

Global Molecular Diagnostics market breakdown & data triangulation

Global Molecular Diagnostics market share analysis

Global Molecular Diagnostics market Risk assessment/limitations

Assessment of the impact of covid-19 on the economic scenario

EXECUTIVE SUMMARY

GLOBAL MOLECULAR DIAGNOSTICS MARKET OUTLOOK / MARKET OVERVIEW

Introduction

Market dynamics

Market drivers

Increasing prevalence of infectious diseases and cancer

Countries

Market restraints

Lack of standardized norms and governing policies

Opportunities

The growing significance of companion diagnostics

Challenges

INDUSTRY INSIGHTS

Introduction

Industry trends

Strategic benchmarking

Pricing analysis

Value chain analysis

Ecosystem analysis

Patent analysis

Trade analysis

IMPACT OF COVID-19 ON THE GLOBAL MOLECULAR DIAGNOSTICS MARKET

GLOBAL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT

Reagents & Kits

Instruments

Software & Service

GLOBAL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY

Polymerase Chain Reaction (PCR)

In-Situ Hybridization

Isothermal Nucleic Acid Amplification Technology (INAAT)

Sequencing, Chips & Microarrays

In Situ Hybridization (ISH)

Others

GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION

Infectious Disease

Blood Screening

Histology & Oncology

Genetic Testing

Others

GLOBAL MOLECULAR DIAGNOSTICS MARKET BY GEOGRAPHY

Overview

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Rest of Europe

Asia Pacific

China

Japan

India

Rest of Asia Pacific

Rest of the World

Latin America

Middle East & Africa

GLOBAL MOLECULAR DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE

Introduction

Footprint analysis of the top players in the global Molecular Diagnostics market

Product & service portfolio matrix

Market share analysis

Company evaluation quadrant

Company evaluation quadrant for start-ups/smes

Competitive scenario

COMPANY PROFILES

(Business overview, Products & services offered, Recent Developments, Competitive analysis, SWOT Analysis,)

  1. Abbott Laboratories
  2. Abbott Molecular
  3. Becton
  4. Dickinson and Company
  5. bioMérieux SA
  6. Cepheid
  7. Hoffmann-La Roche Ltd.
  8. Grifols International, S.A.
  9. Hologic, Inc.
  10. QIAGEN N.V.
  11. QuestDiagnostics, Inc.
  12. Siemens Healthcare GmbH
  13. Tecan Group Ltd.
  14. The ELITechGroup
  15. Thermo Fisher Scientific
  16. Others 65 +.

APPENDIX

  • Discussion guide
  • Available customizations
  • Related reports

Methodology

Research Methodology is the process used to collect information and data for the purpose of making business decisions. The success of a research project is entirely dependent on the research methodology adopted by the company. Research Methodology and Scope We have implemented a mix of primary and secondary research for our market estimate and forecast. Secondary research formed the initial phase of our study, where we conducted extensive data mining, referring to verified data sources such as independent studies, company annual reports, white papers, case studies, government and regulatory published articles, technical journals, magazines, and paid data sources. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

In the primary research process, various primary sources from both supply and demand sides have been interviewed to obtain qualitative and quantitative information important for respective regions. The primary sources from the supply side included industry experts such as CEOs, VPs, marketing directors, technology and innovation directors, and related executives from key companies and organizations operating in the respective regions. The primary data has been collected through questionnaires, e-mails, and telephonic interviews, end-user surveys, consumer surveys, technology distributors and wholesaler’s surveys.

  • Quantitative methods (e.g. surveys) are best for measuring, ranking, categorizing, identifying patterns and making generalizations
  • Qualitative methods (e.g. interviews) are best for describing, interpreting, contextualizing, and gaining in-depth insight into specific concepts or phenomena
  • Mixed methods allow for a combination of numerical measurement and in-depth exploration.

Market drivers and restraints, along with their current and expected impacts, technological scenario and expected developments, end-use industry trends and dynamics  and consumer behavior trends  these forecasting parameters were considered.

Ethical approach, attention to detail, consistency, latest trend in the market and highly authentic source these are benefits of company’s research methodology.

Global Industry Reports

Market size estimation methodology top-down and bottom-up approaches

Both top-down and bottom-up approaches have been used to estimate and validate the total size of the virtual reality market. These methods have also been extensively used to estimate the sizes of various market subsegments. Estimating the size of the market in each region by adding the sizes of country-wise markets and tracking the ongoing and upcoming implementation of virtual reality projects by various companies in each region and forecasting the size of the virtual reality market based on these developments and other critical parameters, including COVID-19 related impacts

Data Triangulation

After arriving at the overall market size—using the market size estimation processes explained above—the market has been split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures have been employed, wherever applicable. The data has been triangulated by studying various factors and trends from both the demand and supply sides. It provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, company profiles, key player strategies competitive developments and key developments) influencing the virtual reality market growth.

Statistical Model

Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis.

Frequently Asked Questions ?

 

The major players in the Global Molecular Diagnostics market are Abbott Laboratories; ABACUS Diagnostica Oy; Agilent Technologies, Inc.; Amoy Diagnostics Co., Ltd.; Becton; BD; bioMerieux SA; Bio-Rad Laboratories, Inc.; Biocartis NV; Cepheid; Dickinson and Company; DiaSorin S.p.A; Danaher Corporation; Exact Sciences Corporation; ELITechGroup; F. Hoffmann-La Roche Ltd.; Grifols International, S.A.; Genetic Signatures; GenMark Diagnostics Inc.; Hologic, Inc.; HTG Molecular Diagnostics; Illumina, Inc.; Luminex Corporation; Myriad Genetics Inc.; MDxHealth; Molbio Diagnostics Pvt. Ltd.; QIAGEN N.V.; QuestDiagnostics, Inc.; Quidel Corporation; Siemens Healthcare GmbH; Sysmex Corporation; Savyon Diagnostics Ltd.;  Tecan Group Ltd.; TBG Diagnostics Ltd.  The ELITechGroup; Thermo Fisher Scientific; Vela Diagnostics and Others.

Players in this market have adopted expansions, acquisitions, and agreements strategies to increase their market share.

Asia Pacific is leading and serving the most significant market share of the Molecular Diagnostics at the global level.

Buy Now